VP5 inhibitors encompasses a variety of compounds that, through different mechanisms, might impact the function of the viral protein VP5. Assuming VP5 is involved in viral entry or replication, inhibitors such as amantadine and rimantadine target the uncoating process of viruses. Compounds like LJ001 and chloroquine that alter viral envelope integrity or endosomal function could affect VP5.
Compounds like aurintricarboxylic acid and ribavirin that inhibit viral nucleic acid release or mimic nucleosides could impact VP5 function indirectl. Immune modulators like IFN-alpha or agents like zinc salts that enhance the antiviral immune response could reduce VP5 levels or activity by creating an intracellular environment less conducive to viral replication. Broad-spectrum antivirals like DRACO or specific protease inhibitors could also affect VP5. This class of inhibitors would, therefore, include diverse chemical entities capable of interfacing with viral life cycle stages or host pathways that VP5 might rely on.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
1-Adamantylamine | 768-94-5 | sc-251475 sc-251475A | 1 g 25 g | $39.00 $147.00 | ||
An adamantane derivative that can inhibit viral uncoating, potentially affecting VP5 function if it is involved in this process. | ||||||
Rimantadine Hydrochloride | 1501-84-4 | sc-205842 sc-205842A | 25 mg 50 mg | $47.00 $104.00 | ||
A derivative of amantadine, which shares a similar mechanism of action and could similarly affect VP5 function if related to viral uncoating. | ||||||
Aurintricarboxylic Acid | 4431-00-9 | sc-3525 sc-3525A sc-3525B sc-3525C | 100 mg 1 g 5 g 10 g | $20.00 $32.00 $48.00 $94.00 | 13 | |
A compound that can inhibit viral replication by preventing the release of viral nucleic acid, potentially affecting VP5 if involved in nucleic acid interactions. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
A nucleoside analog that interferes with viral replication and could indirectly affect VP5 if it plays a role in viral RNA synthesis. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions have been shown to inhibit viral replication and might indirectly affect VP5 if it is involved in this process. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
A compound known to alter endosomal pH, which could affect viral entry and uncoating, potentially impacting VP5 if it is involved in these stages. | ||||||